Related Experiment Videos
Antiphospholipid syndromes and the nervous system. Clinical features, mechanisms, and treatment
1Clinical Stroke Service, University of Michigan Medical School, Detroit.
Seminars in Neurology
|June 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2013
Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2007
Factors determining headache at onset of acute ischemic stroke.
Cephalalgia : an international journal of headache·2006
Clinical Syndromes of Peripheral Nervous System Neurotoxicity from Immune-Checkpoint Inhibitors.
Seminars in neurology·2026
Neurologic Complications of Cancer Immunotherapy.
Seminars in neurology·2026
Non-stenotic Carotid Disease: Review of the Literature and Case Discussion of TCAR for Treatment.
Seminars in neurology·2026
Isolated Cranial Tremors: A Reappraisal.
Seminars in neurology·2026
Carotid Revascularization Protocol for Symptomatic Stenosis.
Seminars in neurology·2026
Approach to the Patient with FND: Evaluation, Diagnosis, and Developing a Treatment Plan.
Seminars in neurology·2026
At-home limbic-targeted transcranial electrical stimulation during sleep: a feasibility study in healthy adults.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026
Early Clinical and Cerebrospinal Fluid Predictors of 1-Year Recurrence in Autoimmune GFAP Astrocytopathy.
Annals of clinical and translational neurology·2026
Prevalence of dysautonomia in chronic musculoskeletal pain: a cross-sectional study.
Rheumatology (Oxford, England)·2026
Molecular arrangement and modulation of extrasynaptic αβδ GABAA receptors.
Nature communications·2026
miR-34a and miR-223 as diagnostic biomarkers for the severity of non-alcoholic fatty liver disease.
Journal, genetic engineering & biotechnology·2026